RAPAMUNE ®
Approved/Launched in September 1999 (U.S.)
- Over 7,000 Transplant Patients Started on RAPAMUNE® Since Launch
European Approval March 2001
- Recognizes Cyclosporine-sparing Effects of RAPAMUNE®
Used by Over 100 of the Top U.S. Transplant Centers
- These Centers Account for ᢋ% of All Transplants in the U.S.
Tablet NDA Approved August 25, 2000; Launch in U.S. 1H 2001
Cyclosporine Elimination sNDA Filed April 2001
Shaping the Art of Immunosuppression